160 related articles for article (PubMed ID: 38486818)
1. The synergy of dual faecal immunochemical and faecal calprotectin testing for accurate assessment of endoscopic and histological activity in inflammatory bowel disease.
Bohra A; Batt N; Dutt K; Lewis D; Segal JP; Newiadomski O; Vasudevan A; Langenberg DRV
Therap Adv Gastroenterol; 2024; 17():17562848241237895. PubMed ID: 38486818
[TBL] [Abstract][Full Text] [Related]
2. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
3. Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity.
Zittan E; Kelly OB; Gralnek IM; Silverberg MS; Hillary Steinhart A
JGH Open; 2018 Oct; 2(5):201-206. PubMed ID: 30483590
[TBL] [Abstract][Full Text] [Related]
4. The Toronto IBD Global Endoscopic Reporting [TIGER] Score: A Single, Easy to Use Endoscopic Score for Both Crohn's Disease and Ulcerative Colitis Patients.
Zittan E; Steinhart AH; Aran H; Milgrom R; Gralnek IM; Zelber-Sagi S; Silverberg MS
J Crohns Colitis; 2022 May; 16(4):544-553. PubMed ID: 34272937
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of Faecal Immunochemical Test to Predict Endoscopic and Histological Healing in Ulcerative Colitis: A Prospective Study Based on Validated Histological Scores.
Shi HY; Chan FKL; Chan AWH; Higashimori A; Kyaw M; Ching JYL; Luk AKC; Wong SH; Wu JCY; Sung JJY; Ng SC
J Crohns Colitis; 2017 Sep; 11(9):1071-1077. PubMed ID: 28881876
[TBL] [Abstract][Full Text] [Related]
7. Fecal immunochemical test for hemoglobin versus fecal calprotectin to monitor endoscopic activity in inflammatory bowel disease.
Latorre Añó P; Torrente Sánchez J; Pérez Ibañez AA; Tenias Burillo JM; Moreno Sánchez NP; López-Serrano A; Moreno Osset E; Murado Pardo J; Paredes JM
Rev Esp Enferm Dig; 2023 Oct; 115(10):553-558. PubMed ID: 37114398
[TBL] [Abstract][Full Text] [Related]
8. Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.
Buisson A; Vazeille E; Minet-Quinard R; Goutte M; Bouvier D; Goutorbe F; Pereira B; Barnich N; Bommelaer G
Aliment Pharmacol Ther; 2016 May; 43(10):1069-79. PubMed ID: 26953251
[TBL] [Abstract][Full Text] [Related]
9. Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Inflammatory Bowel Disease.
Swaminathan A; Borichevsky GM; Edwards TS; Hirschfeld E; Mules TC; Frampton CMA; Day AS; Hampton MB; Kettle AJ; Gearry RB
J Crohns Colitis; 2022 Dec; 16(12):1862-1873. PubMed ID: 35803583
[TBL] [Abstract][Full Text] [Related]
10. Improved monitoring of inflammatory activity in patients with ulcerative colitis by combination of faecal tests for haemoglobin and calprotectin.
Karling P; Lundgren D; Eklöf V; Palmqvist R; Hultdin J
Scand J Clin Lab Invest; 2019 Sep; 79(5):341-346. PubMed ID: 31164011
[TBL] [Abstract][Full Text] [Related]
11. Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease.
Farias E Silva K; Nanini HF; Cascabulho CM; Rosas SLB; Santana PT; Carneiro AJV; Anaissie E; Nucci M; de Souza HSP
World J Gastroenterol; 2021 Mar; 27(9):866-885. PubMed ID: 33727775
[TBL] [Abstract][Full Text] [Related]
12. Faecal Calprotectin Predicts Endoscopic and Histological Activity in Clinically Quiescent Ulcerative Colitis.
Hart L; Chavannes M; Kherad O; Maedler C; Mourad N; Marcus V; Afif W; Bitton A; Lakatos PL; Brassard P; Bessissow T
J Crohns Colitis; 2020 Jan; 14(1):46-52. PubMed ID: 31314884
[TBL] [Abstract][Full Text] [Related]
13. Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease.
Shimizu H; Ebana R; Kudo T; Sato T; Hara T; Hosoi K; Usami M; Yoshida M; Takeuchi I; Nakase H; Iwama I; Arai K; Shimizu T
J Gastroenterol; 2022 May; 57(5):344-356. PubMed ID: 35165800
[TBL] [Abstract][Full Text] [Related]
14. Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients.
Cannatelli R; Bazarova A; Zardo D; Nardone OM; Shivaji U; Smith SCL; Gkoutos G; Ricci C; Gui XS; Ghosh S; Iacucci M
Inflamm Bowel Dis; 2021 Apr; 27(5):647-654. PubMed ID: 32592477
[TBL] [Abstract][Full Text] [Related]
15. A Specific Calprotectin Neo-epitope [CPa9-HNE] in Serum from Inflammatory Bowel Disease Patients Is Associated with Neutrophil Activity and Endoscopic Severity.
Mortensen JH; Sinkeviciute D; Manon-Jensen T; Domislović V; McCall K; Thudium CS; Brinar M; Önnerfjord P; Goodyear CS; Krznarić Ž; Karsdal MA; Bay-Jensen AC
J Crohns Colitis; 2022 Sep; 16(9):1447-1460. PubMed ID: 35304895
[TBL] [Abstract][Full Text] [Related]
16. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
[TBL] [Abstract][Full Text] [Related]
17. Surrogate Markers of Intestinal Inflammation in Paediatric Patients with Inflammatory Bowel Disease.
Shentova R; Baycheva M; Kofinova D; Hadjiiski P; Yaneva P
Folia Med (Plovdiv); 2020 Jun; 62(2):271-275. PubMed ID: 32666743
[TBL] [Abstract][Full Text] [Related]
18. Rapid faecal tests for detecting disease activity in colonic inflammatory bowel disease.
Puolanne AM; Kolho KL; Alfthan H; Ristimäki A; Mustonen H; Färkkilä M
Eur J Clin Invest; 2016 Oct; 46(10):825-32. PubMed ID: 27438629
[TBL] [Abstract][Full Text] [Related]
19. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
[TBL] [Abstract][Full Text] [Related]
20. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
